When insulin is used in both the hospitalized and nonhospitalized setting, it is important to match the pharmacokinetics of the GC preparation with the precise insulin regimen in order to optimize glucose control and reduce the risk of hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.